Home 
Overactive Bladder (OAB) Cognitive Dysfunction with Tolterodine Use - Abstract
Overactive Bladder (OAB) Cognitive Dysfunction with Tolterodine Use - Abstract | Cognitive Dysfunction with Tolterodine Use - Abstract |
|
|
|
|
|
| Wednesday, 22 August 2007 | ||
|
Department of Obstetrics and Gynecology, University of Insubria, Del Ponte Hospital, Varese, Italy.
This email address is being protected from spam bots, you need Javascript enabled to view it
This is the first case of a 65 year old healthy woman developing de novo mental confusion during treatment with 2 mg tolterodine twice daily. It is a rare complication of therapy for overactive bladder and resolved when dosage was reduced to 1 mg, although overactive bladder symptoms were still controlled. Written by Salvatore S, Serati M, Cardozo L, Uccella S, Bolis P. Reference Am J Obstet Gynecol. 2007 Aug;197(2):e8
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
Visitor Ratings:
No Affiliation:
5 (1 votes)
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |
